openPR Logo
Press release

Gout Therapeutics Market - Notable Growth Highlights 2025 | GlaxoSmithKline, ChemoCentryx

02-11-2019 01:25 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: TMR Research

/ PR Agency: TMR Research
Gout Therapeutics Market - Notable Growth Highlights 2025 |

Global Gout Therapeutics Market: Snapshot

The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications.

Patients with multiple episodes of severe gout attacks every year or with tophi on examination need to be put on uric acid lowering therapy. Using uric acid lowering agents helps reduce the frequency of gout attacks, and reduces tophi formation with reduced risk of joint destruction.

The effective management of gout involves a set of general principles regardless of the anti-inflammatory agent that is used. This includes early treatment, duration of therapy, gout flare prophylaxis, continuing urate-lowering therapy during attacks, tophaceous gout, comorbidities, and adjunctive measures.

Request Sample Copy of the Report @ www.tmrresearch.com/sample/sample?flag=B&rep_id=2549

Several different therapies, which include systemic and intraarticular glucocorticoids, colchicine, and nonsteroidal anti-inflammatory drugs are effective for the treatment of severe gout; however, there is no single best agent that works for all patients experiencing a severe flare of gout. The availability of a host of agents and treatment approaches likely to benefit gives the opportunity to choose which therapy is likely to work. The agent and therapy can be chosen depending on an assessment of specific symptoms and severity of the condition for a patient and the flare history, and which is most likely to provide benefit minimizing the risk of adverse therapeutic effects.

Global Gout Therapeutics Market: Overview

Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries. But in the recent times, especially in the U.S., the prevalence of gout has increased to greater extents, which is a reflection of growing population with obesity, smoking habits, and increased intake of alcohol. Increased level of uric acid in the body and uncontrolled metabolic disorders are some of the common symptoms of gout.

There are a number of therapies available for the treatment of gout, which also helps in preventing future flares and reduce the risk of kidney stone. These therapies help in reducing the uric acid levels in the body as well as enhance kidney’s ability to discard uric acid via urine. Consequently, the demand in the global gout therapeutics market is expected to increment at a healthy CAGR during the forecast period of 2017 to 2025.

Global Gout Therapeutics Market: Key Trends

Increased research and development in the field has yielded significantly more effective medications in the recent times, which are recommended to patients on the basis of severity of the condition. Introduction of urate-lowering agents is one of the primary driver of the gout therapeutics market. First line therapies such as Febuxostat and Allopurinol are now replaced urate-lowering agents such as Lesinurad, which help in reducing pain as well as negotiate the risk of joint destruction. The growing popularity of OTC drugs such as Oral colchicine, corticosteroids, and NASAIDs, which are quite effective in moderate gout indications, are also favoring the global gout therapeutics market in the positive direction. Technological advancements in medical imaging is another factor augmenting the demand in the gout therapeutics market. On the other hand, low levels of physician and patient awareness, heavy dependency on generic drugs, and use of CAM for the treatment of gout are restraining factors over the global gout therapeutics market.

Request TOC of the Report @ www.tmrresearch.com/sample/sample?flag=T&rep_id=2549

Global Gout Therapeutics Market: Market Potential

Focus on regenerative medicines, high growth potential of biologics, and preference of combination therapies such as are some of the trends that bode well for the future of gout therapeutics market. Biologics such as Canakinumab, Rilonacept, and Krystexxa have been proven to efficiently address gout-related conditions. Combination therapies such as allopurinol and benzbromarone are able to treat gout by reducing the renal dyfunction.

Global Gout Therapeutics Market: Regional Outlook

Currently, North America serves the maximum demand in the global gout therapeutics market, owing to the presence of several prominent players in the U.S., high cost of branded therapies in the U.S., and growing use of gout therapy. Throughout the forecast period, North America is expected to remain the most lucrative market, also gaining traction from impending launch of several urate-lowering agents. On the other hand, vastly populated Asia Pacific is another lucrative region for the vendors venturing in this market. This region not only has a large pool of patients, improving healthcare infrastructure in emerging economies such as India, Japan, and Malaysia as well as changing lifestyle with smoking- and alcohol-related diseases will further escalate the demand in the gout treatment market.

Global Gout Therapeutics Market: Competitive Landscape

Horizon Pharma, AstraZeneca, and Takeda Pharmaceuticals are identified as the most prominent companies in moderately consolidated market for gout therapeutics. These companies lead via research and development and have a profile of drugs with high efficacy.

Read Comprehensive Overview of Report @ www.tmrresearch.com/gout-therapeutics-market

Novartis, Eli Lilly, Alder Biopharmaceuticals, Can-Fite BioPharma, Celgene, Ablynx, Lexicon Pharmaceuticals, Merck, Boehringer Ingelheim, Celltrion, CymaBay Therapeutics, GlaxoSmithKline, ChemoCentryx, Gilead Sciences, Ironwood Pharmaceuticals, Incyte, KaloBios Pharmaceuticals, Morphotek, Sanofi, Santarus, and Selecta Biosciences are some of the other key companies in the global gout therapeutics market.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gout Therapeutics Market - Notable Growth Highlights 2025 | GlaxoSmithKline, ChemoCentryx here

News-ID: 1577003 • Views: 96

More Releases from TMR Research

Hydrolyzed Plant Proteins Market Booming Global Industry Investments and future …
Global Hydrolyzed Plant Proteins Market: Overview Hydrolyzed plant proteins have found use in a wide range of applications in the food and beverages industry. Most commonly, the protein is used to enhance flavor in several processed food products. Several functional characteristics are key to the growing popularity of these proteins. Proteins from oil-producing plants have excellent fat binding and emulsification properties, which are being utilized by hydrolyzing these for applications that
Rose Extracts Market 2028 | Young Living Essential Oils, Thracian Oils Ltd., Fle …
Global Rose Extracts Market: Overview Pharmacological properties of key species of rose flowers are well known, and several companies have been utilizing these for skin care. This is one of the key trends propelling the steady evolution of the rose extracts market. A growing body of in-vivo and in-vitro clinical studies over the past few years have underscored the therapeutic potential of rose extracts. In skin care, rose extracts have been
Global Fruit Tea Market Analysis, Size, Share, Growth & Forecast 2018-2028: Tata …
Global Fruit Tea Market: Overview Based on the nutritive value like vitamin C, and health benefits such as great antioxidant are some of the reasons that are boosting the demand for fruit tea across the globe. Moreover, the growing popularity of the beverage in health cautious genre of population is also a crucial factor that is propelling the demand for fruit tea market. Based on these factors the global fruit
Dairy Desserts Market 2028 | General Mills Inc., Royal FrieslandCampina NV, Nest …
Global Dairy Desserts Market: Overview Who doesn’t love a good dessert after a delicious dinner or lunch? Though they are filled with high calories, they are highly in demand. However, dairy desserts are something that everybody cherishes. The variety in taste and shapes, they are being loved by every age group. Based on the delicious taste and widespread acceptance the global dairy desserts market is expected to grow substantially in the

All 5 Releases


More Releases for Gout

Gout Therapeutics Market Is Booming Worldwide | Takeda Pharmaceutical Company, N …
HTF MI recently introduced Global Gout Therapeutics Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Takeda Pharmaceutical Company, Novartis, AstraZeneca, GlaxoSmithKline, Merck & Regeneron Pharmaceuticals etc.
Gout Therapeutics Market - Growth Management 2017-2025
Global Gout Therapeutics Market: Snapshot The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications. Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2549 Patients with multiple episodes of
Gout Therapeutics Market Moderately consolidated by 2025
Global Gout Therapeutics Market: Snapshot The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications. Patients with multiple episodes of severe gout attacks every year or with
Gout Therapeutics Market - High Growth Rate Foreseen during 2017 - 2025
Global Gout Therapeutics Market: Snapshot The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications. Patients with multiple episodes of severe gout attacks every year or with
Gout Therapeutics Market - Future Growth & Forecast 2017-2025
Global Gout Therapeutics Market: Overview Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries. But in the recent times, especially in the U.S., the prevalence of gout has increased to greater extents, which is a reflection of growing population with obesity, smoking habits, and increased intake of alcohol. Increased level of uric acid in the
Gout Therapeutics - Emerging Markets in Developing Countries
Qyresearchreports include new market research report Gout Therapeutics to its huge collection of research reports. The global market for Gout Therapeutics is discussed in detail within a new research study added recently to QYResearchReports.com. The report has been carefully examined both qualitatively and quantitatively and the results are revealed in the research report for the forecast period of 2017 to 2022. In addition to this, the various drivers and restraints, regulatory